Purpose

The purpose of this study is to assess the feasibility of using a virtual reality headset (VRH) during endoscopy and its impact on the endoscopist ergonomics. We will use the Apple Vision Pro during approximately 140 endoscopic procedures during which ergonomics will be assessed.

Conditions

Eligibility

Eligible Ages
All ages
Eligible Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Endoscopist: endoscopist at Cleveland Clinic Weston who consent to participate in the study and are performing either colonoscopy, EUS, or ERCP. - Patient: patient undergoing colonoscopy, EUS, or ERCP

Exclusion Criteria

  • Exclude the following procedures: Device-assisted colonoscopy (e.g.- double balloon, pathfinder, etc) - ERCP in native papilla - Cholangioscopy - Therapeutic EUS procedures (FNA/FNB, Stent Placement) - Planned Mucosal Resection of Polyps > 20 mm - Inpatient procedures - Aborted procedures

Study Design

Phase
N/A
Study Type
Interventional
Allocation
Non-Randomized
Intervention Model
Sequential Assignment
Primary Purpose
Prevention
Masking
None (Open Label)

Arm Groups

ArmDescriptionAssigned Intervention
Active Comparator
NonVRH
Endoscopic procedure without virtual reality headset (VRH)
  • Other: MYSELF checklist
    A preprocedural timeout to improve ergonomics.
Active Comparator
VRH
Endoscopic procedure completed with virtual reality headset (VRH)
  • Device: Virtual reality headset
    Use of the virtual reality headset during endoscopic procedures.
  • Other: MYSELF checklist
    A preprocedural timeout to improve ergonomics.

Recruiting Locations

Cleveland Clinic Weston
Weston, Florida 33331
Contact:
Tilak Shah, MD
877.463.2010
SHAHT3@ccf.org

More Details

Status
Recruiting
Sponsor
The Cleveland Clinic

Study Contact

Notice

Study information shown on this site is derived from ClinicalTrials.gov (a public registry operated by the National Institutes of Health). The listing of studies provided is not certain to be all studies for which you might be eligible. Furthermore, study eligibility requirements can be difficult to understand and may change over time, so it is wise to speak with your medical care provider and individual research study teams when making decisions related to participation.